Clinical Trials Directory

Trials / Completed

CompletedNCT05888779

Beverages for Thought: Exploring the Relationship Between Blood Glucose and Cognition

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
USDA Grand Forks Human Nutrition Research Center · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to conduct novel research on the relationship between blood sugar and cognition.

Detailed description

This study is an acute parallel study design with one intervention visit needed per participant. There are 2 groups and 80 participants will be randomized into each group. Following the consent process, participants in each group will be seated individually in quiet rooms, with written instructions, several magazines, and a mini-fridge with beverages containing 110-120 kcals/8 fl oz. Participants will be provided instructions for the study, stating, "The study we are conducting explores the relationship between blood glucose and cognitive abilities. After consuming food or drink, your body regulates your blood glucose. Physical exertion can also affect blood glucose. Therefore, we ask that you relax in this space for 10-15 minutes. You can read the provided magazines during this time. Drinking a beverage will bring your body's blood glucose into the right phase for our questionnaires. In the fridge are some beverages, and we ask that you drink something." After 10-15 minutes, participants will be given a cognitive test (a questionnaire on paper) and asked to complete as much of it as they can within 5 minutes. Then, moving to a separate area, weight and height measurements will be taken.

Conditions

Interventions

TypeNameDescription
OTHERBeverage One (Milk)Participant will consume beverage one (milk) and complete novel cognitive assessment questionnaire on paper.
OTHERBeverage Two (Juice)Participant will consume beverage two (fruit drink) and complete novel cognitive assessment questionnaire on paper.

Timeline

Start date
2023-06-23
Primary completion
2025-04-11
Completion
2025-04-11
First posted
2023-06-05
Last updated
2025-04-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05888779. Inclusion in this directory is not an endorsement.